Our Portfolio

We develop, manufacture and market versatile noninvasive alcohol testing systems for both existing and emerging markets. TruTouch’s patented, revolutionary technology is the fruit of a ten-year, $60-million investment in developing noninvasive, spectroscopy-based systems for biomedical applications.

TruTouch Technologies develops and manufactures revolutionary technology for how we measure – in real-time -the condition of the human body. The non-invasive, light-based device used reflected light to achieve fast and accurate results. Our technology is the product of over 20 years of research and 65 worldwide patents and patent applications, multiple generations of products, and millions of real-world tests, with next-generation products being deployed in a trial vehicle fleet in late 2018.

TruTouch is currently developing the next generation of alcohol detection sensors for use in vehicles under the DADSS (www.DADSS.org) program. The DADSS research program brings together the National Highway Traffic Safety Administration (NHTSA) and the Automotive Coalition for Traffic Safety (ACTS) to collaborate and translate TruTouch’s technology into vehicular components and expand the touch-based sensor applications.

TruTouch Technologies ceased operations in 2021 with no realized return to investors.